Taylor Wessing advises Oxbotica in $47 million Series B investment
On 6 January 2021, Oxbotica, a global leader in autonomous vehicle software, announced the completion of a $47 million Series B investment with partners across the globe led by bp ventures.
Taylor Wessing advises UK fintech Curve on $95M funding round ahead of US launch
Taylor Wessing has advised UK fintech Curve on its USD$95 million Series C fundraising round in anticipation of its US launch and further European growth.
Taylor Wessing creates one of the largest private wealth teams in European market with new hires
International law firm Taylor Wessing has further enhanced its international private wealth capability, creating one of the largest private wealth teams by total number of lawyers in the European market with the hire of a team of lawyers from Bryan Cave Leighton Paisner.
Taylor Wessing discusses the impact of vaccination in the return to the office, with Financial News
Requiring employees to get vaccinated before coming back to the workplace is the closest way to eliminating risk of infection at work.
Taylor Wessing adds support for better representation of black talent through the 10,000 Black Interns programme
Taylor Wessing is delighted to announce its participation in the 10,000 Black Interns programme - an initiative to help transform the horizons and prospects of young Black students in the United Kingdom.
Taylor Wessing's Budapest team moves into a new office
Taylor Wessing's Budapest office, which has been present in Hungary for 25 years, has moved into a new office.
What you need to know about the new National Security and Investment Bill
On 11 November 2020, the UK government introduced the National Security and Investment Bill, which establishes a new screening regime for transactions that might raise national security concerns. Paolo Palmigiano, head of Taylor Wesssing's UK Competition, EU and Trade practice, outlines its implications...
Taylor Wessing recognised in 'The Times' Best Law Firms for third consecutive year
Taylor Wessing has been recognised in The Times Best Law Firms 2021.
Taylor Wessing advises on major healthcare sale of Nucleus Global to Huntsworth
Taylor Wessing has advised on the sale of specialist medical communications group, Nucleus Global, to international healthcare and communications group Huntsworth. The sale is subject to German competition authority clearance.
The medical device regulatory regime in Great Britain and Northern Ireland after 31 December 2020
The UK exited the European Union (EU) on 31 January 2020. A transition period exists until 31 December 2020, during which time medical devices continue to be regulated as if the UK is still a part of the EU.
Taylor Wessing discusses the use of the NHS COVID-19 App
The NHS COVID-19 App was introduced in the UK on 24 September. Many welcome its arrival as another step to contain the spread of COVID-19, while others are concerned about using the app for data and privacy reasons.
Taylor Wessing announces five UK appointments to partnership for 2020
Taylor Wessing has announced that five of its lawyers in the UK have been promoted to join the partnership with effect from 1 November 2020*.
Taylor Wessing experts discuss the future of technology, life sciences and private wealth with 'Legal Cheek'
Graham Hann, Tasmina Goraya, and Ronald Graham of Taylor Wessing discuss how the technology, life sciences and private wealth sectors will shape the post-pandemic world, and the opportunities they anticipate over the years ahead.
Taylor Wessing provides legal advice to marine conservation charity
Taylor Wessing has advised the marine conservation charity, Surfers Against Sewage, with the drafting of precedent sponsorship agreements and legal contracts.
Katie Chandler comments on UK High Court's business interruption judgment for IBA Global Insight
Many UK policyholders whose businesses suffered losses during the COVID-19 pandemic have received a welcome boost from the country’s High Court.
Alison Dennis discusses the importance of IP protection for healthtech companies with First Word MedTech
In the fast-expanding healthtech landscape, with a constant stream of new products entering the market, a company's intellectual property (IP)—the secret sauce that differentiates their technology from competitors' offerings—holds more value than ever.
Taylor Wessing attracts new corporate technology and private equity partner
International law firm Taylor Wessing announces the appointment of Ian Moore as a partner in its corporate technology and private equity teams.
Paul England discusses IP and pharma changes of the past decade, for Intellectual Property Magazine
Just a decade ago, during the financial crisis, the life sciences sector, dominated by small-molecule pharmaceuticals, was being squeezed.
Chris Jeffery of Taylor Wessing discusses social distancing tech in 'Verdict' Magazine
From fashion, to fitness, to health, to communication, connected wearable devices have been making inroads in a number of industries, and are now a well-established segment of the internet of things. Wearable devices have played a role in remote patient monitoring during the pandemic, but the technology is now also being explored as a means of tackling the issue of social distancing, particularly…
Taylor Wessing is named Legal Business' Legal Technology Team of the Year
Taylor Wessing has been crowned the "standout choice" and winner of Legal Technology Team of the Year at the Legal Business Awards 2020.
Adam Rendle outlines potential changes in UK copyright law
The UK has the opportunity, post-Brexit, to make considerable changes to its copyright law once it’s no longer subject to the restrictions of the EU’s suite of copyright directives and regulations.
Mark Owen and Maria Luchian discuss the European AI and data strategy
In her political guidelines, European Commission President Ursula von der Leyen set out her vision for a Europe fit for the digital age, which includes defining standards for new technologies, intended to become global norms.
How biotech has managed its finances during the pandemic
The COVID-19 pandemic has had huge knock-on effects on economies around the world.
Alison Dennis discusses the new framework for regulating medical devices and IVDs
As the UK leaves the EU, a new framework for regulating medical devices and IVDs will come into place at the start of next year.
Taylor Wessing advises international investor group on the acquisition of Kümpers Composites
A consortium of investors based in Singapore has taken over 95 percent of Kümpers Composites GmbH & Co KG.